Related Experiment Videos

Laryngeal aspergillosis in an acquired immunodeficiency syndrome patient

C Delbrouck1, G Chantrain, S Kampouridis

  • 1Department of Otolaryngology, C.H.U. Saint-Pierre, Belgium.

Insights

Aspergillosis is a rare fungal infection, particularly severe in immunocompromised individuals. Early, aggressive treatment with antifungals like amphotericin B is crucial for better outcomes.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Aspergillosis is a rare fungal infection with variable virulence, especially in immunocompromised patients.
  • Severe cases involve vascular invasion, tissue infarction, and necrosis, often originating in the lungs.

Observation:

  • Laryngeal aspergillosis is an exceptional manifestation, typically secondary to lower airway infection.
  • Diagnostic challenges include low culture positivity rates (50%) and characteristic histological findings often identified postmortem (60%).

Findings:

  • The condition presents significant morbidity and mortality, particularly in individuals with acquired immunodeficiency syndrome (AIDS).
  • Characteristic histological features resemble 'sprigs of mistletoe'.

Implications:

  • Early and aggressive treatment is essential for patients with acquired immunodeficiency syndrome (AIDS).
  • Treatment primarily relies on antifungal medications such as amphotericin B and itraconazole.

Related Concept Videos